Biospective Inc.

biospective inc. is a specialty contract research organization (cro) with particular strengths in cns diseases and disorders, including alzheimer’s disease, parkinson’s disease, multiple sclerosis, als, schizophrenia, and depression. our unique, state-of-the-art technologies and world-class scientific pre-clinical and clinical expertise accelerates the drug discovery timeline. biospective provides industry-leading services in several cores areas: animal models and behavioral assays; animal imaging (nightwing™ platform), histology, and quantitative ihc (permits™ platform); and human mri, fmri, pet, and spect imaging (piano™ platform). these platforms represent some of biospective’s fully-automated, unbiased, and high-throughput technologies that provide sponsors with an unparalleled ability to assess the efficacy of their novel therapeutic agents throughout preclinical and clinical drug development.